| 000 | 01741 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514004705.0 | ||
| 264 | 0 | _c20020328 | |
| 008 | 200203s 0 0 eng d | ||
| 022 | _a0028-1298 | ||
| 024 | 7 |
_a10.1007/s002100000391 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGögelein, H | |
| 245 | 0 | 0 |
_aEffects of the cardioselective KATP channel blocker HMR 1098 on cardiac function in isolated perfused working rat hearts and in anesthetized rats during ischemia and reperfusion. _h[electronic resource] |
| 260 |
_bNaunyn-Schmiedeberg's archives of pharmacology _cJul 2001 |
||
| 300 |
_a33-41 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnesthesia |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Arrhythmia Agents _xpharmacology |
| 650 | 0 | 4 |
_aBenzamides _xadministration & dosage |
| 650 | 0 | 4 |
_aGlyburide _xpharmacology |
| 650 | 0 | 4 |
_aHeart _xdrug effects |
| 650 | 0 | 4 |
_aHemodynamics _xdrug effects |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aModels, Animal |
| 650 | 0 | 4 |
_aMyocardial Contraction _xdrug effects |
| 650 | 0 | 4 | _aMyocardial Infarction |
| 650 | 0 | 4 |
_aMyocardial Ischemia _xphysiopathology |
| 650 | 0 | 4 | _aMyocardial Reperfusion |
| 650 | 0 | 4 |
_aPotassium _xmetabolism |
| 650 | 0 | 4 |
_aPotassium Channel Blockers _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aSulfonamides _xpharmacology |
| 650 | 0 | 4 |
_aThiourea _xanalogs & derivatives |
| 700 | 1 | _aRuetten, H | |
| 700 | 1 | _aAlbus, U | |
| 700 | 1 | _aEnglert, H C | |
| 700 | 1 | _aBusch, A E | |
| 773 | 0 |
_tNaunyn-Schmiedeberg's archives of pharmacology _gvol. 364 _gno. 1 _gp. 33-41 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s002100000391 _zAvailable from publisher's website |
| 999 |
_c11411997 _d11411997 |
||